Saturday Evening Post - New drug update
M2 PRESSWIRE-19 June 2007-Biotech News: Shareholders alert for Bristol-Myers Squibb Co(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:19062007 Shareholders alert for Bristol-Myers Squibb Co (NYSE:BMY) Bristol-Myers Squibb Company (BMS) engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals, and related health care products worldwide.
Related Results
Legal battles rage in the marketing war over warfarin
Vitamin K and “Koffee.” (significant amount of vitamin K present in…
Iverson Genetic Diagnostics Offers FDA Cleared Warfarin Test
Daxor Announces Alfieri Cardiology of Newark, DE Acquires Blood Volume Analyz…
DuPont to Sell Pharmaceutical Unit to Bristol-Myers Squibb for $7.8 Billion.
It operates in three segments: Pharmaceuticals, Nutritionals, and Other Health Care. The Pharmaceuticals segment offers cardiovascular products, including PLAVIX, PRAVACHOL, COUMADIN, and …
Read the rest of this article with a Free Trial at HighBeam Research.
